Cargando…
Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
INTRODUCTION: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). METHODS: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801325/ https://www.ncbi.nlm.nih.gov/pubmed/36589251 http://dx.doi.org/10.1159/000526495 |
_version_ | 1785145825406484480 |
---|---|
author | Mintziras, Ioannis Wächter, Sabine Manoharan, Jerena Kanngiesser, Veit Maurer, Elisabeth Bartsch, Detlef K. |
author_facet | Mintziras, Ioannis Wächter, Sabine Manoharan, Jerena Kanngiesser, Veit Maurer, Elisabeth Bartsch, Detlef K. |
author_sort | Mintziras, Ioannis |
collection | PubMed |
description | INTRODUCTION: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). METHODS: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined as an elevation of serum pancreatic amylase above the upper limit of normal (53 U/L) on postoperative days 0–2. Clinically relevant POH (cr-POH) was defined as POH in patients with clinically relevant (Clavien-Dindo ≥ III) postoperative complications. RESULTS: POH occurred in 61 of 170 (35.9%) and cr-POH in 24 of 170 (14.1%) patients. Patients with POH had higher rates of clinically relevant postoperative pancreatic fistula (cr-POPF) (44.3 vs. 3.7%, p < 0.001) and clinically relevant postoperative complications than those without POH (39.3 vs. 21.1%, p = 0.001). Patients with cr-POH had higher C-reactive protein (CRP, milligrams per liter) levels on third (257.7 vs. 187.85 mg/L, p = 0.016) and fourth (222.5 vs. 151, p = 0.002) postoperative day (POD) than those with POH alone. Serum procalcitonin (PCT, micrograms per liter) levels on POD 2 (1.2 vs. 0.4 μg/L, p = 0.028) and POD 3 (0.85 vs. 0.4 μg/L, p = 0.001) were also higher in patients with cr-POH. Rates of cr-POPF in patients with cr-POH were higher than in those with POH alone (70.8 vs. 27%, p = 0.001). POH (OR 0.011, 95% CI: 0.001–0.097, p < 0.001) was an independent predictor of cr-POPF in the multivariable analysis. A high-risk pathology, defined as nonadenocarcinoma/nonchronic pancreatitis pathology (OR 0.277, 95% CI: 0.106–0.727, p = 0.009), and a small duct diameter (OR 0.333, 95% CI: 0.139–0.796, p = 0.013) were independent predictors of POH in the multivariable analysis. CONCLUSION: POH is a frequent, but not always clinically relevant, finding after partial PD. Serum CRP and PCT levels in the early postoperative period can be used to identify patients with cr-POH. POH is an independent risk factor for increased postoperative morbidity, including cr-POPF, after partial PD. |
format | Online Article Text |
id | pubmed-9801325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-98013252023-12-01 Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy Mintziras, Ioannis Wächter, Sabine Manoharan, Jerena Kanngiesser, Veit Maurer, Elisabeth Bartsch, Detlef K. Visc Med Research Article INTRODUCTION: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). METHODS: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined as an elevation of serum pancreatic amylase above the upper limit of normal (53 U/L) on postoperative days 0–2. Clinically relevant POH (cr-POH) was defined as POH in patients with clinically relevant (Clavien-Dindo ≥ III) postoperative complications. RESULTS: POH occurred in 61 of 170 (35.9%) and cr-POH in 24 of 170 (14.1%) patients. Patients with POH had higher rates of clinically relevant postoperative pancreatic fistula (cr-POPF) (44.3 vs. 3.7%, p < 0.001) and clinically relevant postoperative complications than those without POH (39.3 vs. 21.1%, p = 0.001). Patients with cr-POH had higher C-reactive protein (CRP, milligrams per liter) levels on third (257.7 vs. 187.85 mg/L, p = 0.016) and fourth (222.5 vs. 151, p = 0.002) postoperative day (POD) than those with POH alone. Serum procalcitonin (PCT, micrograms per liter) levels on POD 2 (1.2 vs. 0.4 μg/L, p = 0.028) and POD 3 (0.85 vs. 0.4 μg/L, p = 0.001) were also higher in patients with cr-POH. Rates of cr-POPF in patients with cr-POH were higher than in those with POH alone (70.8 vs. 27%, p = 0.001). POH (OR 0.011, 95% CI: 0.001–0.097, p < 0.001) was an independent predictor of cr-POPF in the multivariable analysis. A high-risk pathology, defined as nonadenocarcinoma/nonchronic pancreatitis pathology (OR 0.277, 95% CI: 0.106–0.727, p = 0.009), and a small duct diameter (OR 0.333, 95% CI: 0.139–0.796, p = 0.013) were independent predictors of POH in the multivariable analysis. CONCLUSION: POH is a frequent, but not always clinically relevant, finding after partial PD. Serum CRP and PCT levels in the early postoperative period can be used to identify patients with cr-POH. POH is an independent risk factor for increased postoperative morbidity, including cr-POPF, after partial PD. S. Karger AG 2022-12 2022-10-24 /pmc/articles/PMC9801325/ /pubmed/36589251 http://dx.doi.org/10.1159/000526495 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher. |
spellingShingle | Research Article Mintziras, Ioannis Wächter, Sabine Manoharan, Jerena Kanngiesser, Veit Maurer, Elisabeth Bartsch, Detlef K. Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy |
title | Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy |
title_full | Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy |
title_fullStr | Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy |
title_full_unstemmed | Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy |
title_short | Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy |
title_sort | clinical implications of postoperative hyperamylasemia after partial pancreaticoduodenectomy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801325/ https://www.ncbi.nlm.nih.gov/pubmed/36589251 http://dx.doi.org/10.1159/000526495 |
work_keys_str_mv | AT mintzirasioannis clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy AT wachtersabine clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy AT manoharanjerena clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy AT kanngiesserveit clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy AT maurerelisabeth clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy AT bartschdetlefk clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy |